We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Stellar Biotechnologies, Inc. (MM) | NASDAQ:SBOT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.05 | 1.06 | 1.08 | 0 | 01:00:00 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
|
On July 19, 2016, Stellar Biotechnologies, Inc. (the Company) issued a press release announcing the formation of Neostell S.A.S. (Neostell), a simplified stock corporation headquartered in France, to carry out the business of the companies joint venture, previously announced on May 11, 2016, to manufacture and sell conjugated therapeutic vaccines using Stellar's Keyhole Limpet Hemocyanin (KLH). A copy of the press release is filed as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: July 19, 2016
|
STELLAR BIOTECHNOLOGIES, INC.
By:
/s/ Kathi Niffenegger
|
|
|
Exhibit No. | Description |
99.1 | Press Release of Stellar Biotechnologies, Inc. dated July 19, 2016 |
1 Year Stellar Biotechnologies Inc. Chart |
1 Month Stellar Biotechnologies Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions